| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-11 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-10 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-10 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-09 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |